v3.25.1
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities    
Net income $ 22.1 $ 30.1
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
MSR valuation adjustment, net increase (decrease) 55.9 31.5
Provision for bad debts (advances and receivables) 4.7 6.9
Provision for (reversal of) representation and warranty obligations 0.3 1.2
Depreciation 1.2 1.4
Amortization of Debt Issuance Costs and Discounts 5.7 8.1
Amortization of intangibles 0.3 0.9
Gain on extinguishment of debt 0.0 (1.4)
Equity-based compensation expense 2.1 2.0
Gain on reverse loans held for investment and HMBS-related borrowings, net (19.0) (11.0)
Gain on loans held for sale, net (11.8) (10.9)
Origination and purchase of loans held for sale (4,273.3) (2,988.9)
Proceeds from sale and collections of loans held for sale 4,114.6 2,604.1
Changes in assets and liabilities:    
Decrease in advances 54.4 73.5
Decrease (increase) in receivables and other assets (27.6) 19.6
Increase (Decrease) in Derivative Assets and Liabilities (16.2) (34.8)
Decrease in other liabilities (52.6) (21.0)
Other, net (8.9) (8.2)
Net cash used in operating activities (148.1) (297.1)
Cash flows from investing activities    
Origination of loans held for investment (277.1) (250.3)
Principal payments received on loans held for investment 786.1 277.0
Purchase of MSRs (98.1) (26.4)
Proceeds from sale of MSRs 4.5 0.1
Acquisition of advances in connection with MSR transactions (2.5) 0.0
Proceeds from sale of advances in connection with MSR transactions 0.3 0.9
Purchase of real estate (2.3) (11.9)
Proceeds from sale of real estate 9.2 7.0
Additions to premises and equipment (0.3) (0.1)
Distribution from (investment in) equity method investee, net 0.0 0.1
Net cash provided by (used in) investing activities 419.8 (3.6)
Cash flows from financing activities    
Repayment of advance match funded liabilities, net (39.6) (59.5)
Repayment of other financing liabilities (17.0) (20.0)
Proceeds from mortgage loan financing facilities, net 43.6 396.8
Proceeds from MSR financing facilities 521.2 377.8
Repayment of MSR financing facilities (342.7) (329.1)
Repurchase of Senior notes 0.0 (45.5)
Payment of debt issuance costs (0.2) (3.0)
Proceeds from other financing liabilities - Sale of MSRs accounted for as secured financing 6.9 4.0
Proceeds from sale of Home Equity Conversion Mortgages (HECM, or reverse mortgages) accounted for as a financing (HMBS-related borrowings) 309.1 247.4
Repayment of HMBS-related borrowings (777.1) (272.1)
Payments of Ordinary Dividends, Preferred Stock and Preference Stock (1.0) 0.0
Payment on exercise of common stock warrants (3.5) 0.0
Net cash provided by (used in) financing activities (300.4) 296.8
Net decrease in cash, cash equivalents and restricted cash (28.7) (3.9)
Cash, cash equivalents and restricted cash at beginning of year 265.6 255.1
Cash, cash equivalents and restricted cash at end of period 236.9 251.2
Supplemental non-cash investing and financing activities:    
Right-of-use asset 0.7 0.1
Lease liability 0.7 0.1
Supplemental Cash Flow Elements [Abstract]    
Cash and cash equivalents 178.0 185.1
Debt service accounts 24.8 37.2
Other restricted cash 34.0 28.9
Total cash, cash equivalents and restricted cash reported in the statements of cash flows $ 236.9 $ 251.2